Loading...
Talphera, Inc.
TLPH•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.43
$0.009(2.06%)
Talphera, Inc. (TLPH) Financial Performance & Income Statement Overview
Review Talphera, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-100.00%
↓ 100.00%
Operating Income Growth
9.69%
↑ 9.69%
Net Income Growth
29.31%
↑ 29.31%
Operating Cash Flow Growth
27.49%
↑ 27.49%
Operating Margin
-51596.30%
↓ 51596.30%
Gross Margin
100.00%
↑ 100.00%
Net Profit Margin
-43122.22%
↓ 43122.22%
ROE
-129.47%
↓ 129.47%
ROIC
-107.11%
↓ 107.11%
Talphera, Inc. (TLPH) Income Statement & Financial Overview
Review Talphera, Inc.'s (TLPH) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $6.68M | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $3.34M | $0.00 | $1.91M | $1.43M |
| Gross Profit | $3.34M | $0.00 | -$1.91M | -$1.43M |
| Gross Profit Ratio | $0.50 | $0.00 | ||
| R&D Expenses | $1.32M | $2.05M | $1.91M | $1.43M |
| SG&A Expenses | $1.67M | $1.70M | $2.36M | $2.80M |
| Operating Expenses | $3.00M | $3.75M | $4.27M | $4.24M |
| Total Costs & Expenses | $6.34M | $3.75M | $4.27M | $4.24M |
| Interest Income | $103000.00 | $155000.00 | $201000.00 | $220000.00 |
| Interest Expense | $0.00 | $0.00 | $213000.00 | $181000.00 |
| Depreciation & Amortization | $0.00 | $396000.00 | $24000.00 | $24000.00 |
| EBITDA | -$1.87M | -$3.35M | -$3.61M | -$3.77M |
| EBITDA Ratio | -$0.28 | |||
| Operating Income | -$3.00M | -$3.75M | -$4.27M | -$4.24M |
| Operating Income Ratio | -$0.45 | |||
| Other Income/Expenses (Net) | $1.13M | $396000.00 | $443000.00 | $283000.00 |
| Income Before Tax | -$1.87M | -$3.35M | -$3.83M | -$3.95M |
| Income Before Tax Ratio | -$0.28 | |||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$24000.00 |
| Net Income | -$1.87M | -$3.35M | -$3.83M | -$3.95M |
| Net Income Ratio | -$0.28 | |||
| EPS | -$0.07 | -$0.13 | -$0.15 | -$0.16 |
| Diluted EPS | -$0.07 | -$0.13 | -$0.15 | -$0.16 |
| Weighted Avg Shares Outstanding | $26.24M | $26.21M | $26.20M | $24.72M |
| Weighted Avg Shares Outstanding (Diluted) | $26.24M | $26.21M | $26.20M | $24.72M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan